Valentin V Rybenkov
Overview
Explore the profile of Valentin V Rybenkov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
980
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao H, Peramuna T, Ajmal S, Wendt K, Petrushenko Z, Premachandra K, et al.
ACS Chem Biol
. 2024 Jun;
19(6):1387-1396.
PMID: 38843873
Chromosome segregation is an essential cellular process that has the potential to yield numerous targets for drug development. This pathway is presently underutilized partially due to the difficulties in the...
2.
Manrique P, Leus I, Lopez C, Mehla J, Malloci G, Gervasoni S, et al.
Commun Chem
. 2024 Apr;
7(1):84.
PMID: 38609430
The ability Gram-negative pathogens have at adapting and protecting themselves against antibiotics has increasingly become a public health threat. Data-driven models identifying molecular properties that correlate with outer membrane (OM)...
3.
Hu Z, Leus I, Chandar B, Sherborne B, Avila Q, Rybenkov V, et al.
J Med Chem
. 2023 Sep;
66(19):13858.
PMID: 37733930
No abstract available.
4.
Gervasoni S, Mehla J, Bergen C, Leus I, Margiotta E, Malloci G, et al.
mBio
. 2023 Jul;
14(4):e0140323.
PMID: 37493633
Transporters of the resistance-nodulation-cell division (RND) superfamily of proteins are the dominant multidrug efflux power of Gram-negative bacteria. The major RND efflux pump of is MexAB-OprM, in which the inner...
5.
Leus I, Weeks J, Bonifay V, Shen Y, Yang L, Cooper C, et al.
Sci Rep
. 2023 Jun;
13(1):8918.
PMID: 37264107
No abstract available.
6.
Leus I, Adamiak J, Chandar B, Bonifay V, Zhao S, Walker S, et al.
Antimicrob Agents Chemother
. 2023 Jan;
67(2):e0137722.
PMID: 36715507
Gram-negative bacteria are notoriously more resistant to antibiotics than Gram-positive bacteria, primarily due to the presence of the outer membrane and a plethora of active efflux pumps. However, the potency...
7.
Manrique P, Lopez C, Gnanakaran S, Rybenkov V, Zgurskaya H
Ann N Y Acad Sci
. 2022 Nov;
1519(1):46-62.
PMID: 36344198
Antibiotics effective against Gram-negative ESKAPE pathogens are a critical area of unmet need. Infections caused by these pathogens are not only difficult to treat but finding new therapies to overcome...
8.
Hu Z, Leus I, Chandar B, Sherborne B, Avila Q, Rybenkov V, et al.
J Med Chem
. 2022 Oct;
65(20):14144-14179.
PMID: 36257060
The clinical success of linezolid for treating Gram-positive infections paired with the high conservation of bacterial ribosomes predicts that if oxazolidinones were engineered to accumulate in Gram-negative bacteria, then this...
9.
Leus I, Weeks J, Bonifay V, Shen Y, Yang L, Cooper C, et al.
Sci Rep
. 2022 May;
12(1):8220.
PMID: 35581346
Two membrane cell envelopes act as selective permeability barriers in Gram-negative bacteria, protecting cells against antibiotics and other small molecules. Significant efforts are being directed toward understanding how small molecules...
10.
Zhao H, Clevenger A, Coburn P, Callegan M, Rybenkov V
Mol Microbiol
. 2022 Jan;
117(4):937-957.
PMID: 35072315
Pseudomonas aeruginosa is a significant opportunistic pathogen responsible for numerous human infections. Its high pathogenicity resides in a diverse array of virulence factors and an ability to adapt to hostile...